82 related articles for article (PubMed ID: 38674302)
61. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
62. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD
Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970
[TBL] [Abstract][Full Text] [Related]
63. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial.
Birgisson H; Påhlman L; Gunnarsson U; Glimelius B;
J Clin Oncol; 2005 Dec; 23(34):8697-705. PubMed ID: 16314629
[TBL] [Abstract][Full Text] [Related]
64. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.
Taylor A; Rockall AG; Reznek RH; Powell ME
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1604-12. PubMed ID: 16198509
[TBL] [Abstract][Full Text] [Related]
65. Preoperative versus postoperative chemoradiotherapy for rectal cancer.
Sauer R; Becker H; Hohenberger W; Rödel C; Wittekind C; Fietkau R; Martus P; Tschmelitsch J; Hager E; Hess CF; Karstens JH; Liersch T; Schmidberger H; Raab R;
N Engl J Med; 2004 Oct; 351(17):1731-40. PubMed ID: 15496622
[TBL] [Abstract][Full Text] [Related]
66. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.
Moore HG; Riedel E; Minsky BD; Saltz L; Paty P; Wong D; Cohen AM; Guillem JG
Ann Surg Oncol; 2003; 10(1):80-5. PubMed ID: 12513965
[TBL] [Abstract][Full Text] [Related]
67. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.
Francois Y; Nemoz CJ; Baulieux J; Vignal J; Grandjean JP; Partensky C; Souquet JC; Adeleine P; Gerard JP
J Clin Oncol; 1999 Aug; 17(8):2396. PubMed ID: 10561302
[TBL] [Abstract][Full Text] [Related]
68. Efficacy and safety of total neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis.
Xiong K; Bao T; Cao Y; Hu W; Deng J; Chen J; Xiao T
Int J Colorectal Dis; 2023 Apr; 38(1):89. PubMed ID: 37004572
[TBL] [Abstract][Full Text] [Related]
69. Total neoadjuvant therapy for rectal cancer: An emerging option.
Ludmir EB; Palta M; Willett CG; Czito BG
Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
[TBL] [Abstract][Full Text] [Related]
70. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview.
Guida AM; Sensi B; Formica V; D'Angelillo RM; Roselli M; Del Vecchio Blanco G; Rossi P; Capolupo GT; Caricato M; Sica GS
Biol Direct; 2022 Jun; 17(1):16. PubMed ID: 35698084
[TBL] [Abstract][Full Text] [Related]
71. Surgical and short-term oncological safety of total neoadjuvant therapy in high-risk locally advanced rectal cancer.
Ng YY; Seow-En I; Chok AY; Lee TS; Palanisamy P; Tan EK
ANZ J Surg; 2024 Feb; 94(1-2):175-180. PubMed ID: 37849414
[TBL] [Abstract][Full Text] [Related]
72. Future direction of total neoadjuvant therapy for locally advanced rectal cancer.
Kagawa Y; Smith JJ; Fokas E; Watanabe J; Cercek A; Greten FR; Bando H; Shi Q; Garcia-Aguilar J; Romesser PB; Horvat N; Sanoff H; Hall W; Kato T; Rödel C; Dasari A; Yoshino T
Nat Rev Gastroenterol Hepatol; 2024 Jun; 21(6):444-455. PubMed ID: 38485756
[TBL] [Abstract][Full Text] [Related]
73. Neoadjuvant treatment of colorectal cancer: comprehensive review.
Smith HG; Nilsson PJ; Shogan BD; Harji D; Gambacorta MA; Romano A; Brandl A; Qvortrup C
BJS Open; 2024 May; 8(3):. PubMed ID: 38747103
[TBL] [Abstract][Full Text] [Related]
74. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?
Ochiai K; Bhutiani N; Ikeda A; Uppal A; White MG; Peacock O; Messick CA; Bednarski BK; You YN; Skibber JM; Chang GJ; Konishi T
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893212
[TBL] [Abstract][Full Text] [Related]
75. Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer.
Bratu LD; Schenker M; Stovicek PO; Schenker RA; Mehedințeanu AM; Berisha TC; Donoiu A; Mogoantă SȘ
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674302
[No Abstract] [Full Text] [Related]
76. Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review.
Mori R; Uemura M; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Mizushima T; Doki Y; Eguchi H
World J Surg Oncol; 2022 May; 20(1):166. PubMed ID: 35619103
[TBL] [Abstract][Full Text] [Related]
77. Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data.
Verrijssen AS; Guillem J; Perez R; Bujko K; Guedj N; Habr-Gama A; Houben R; Goudkade D; Melenhorst J; Buijsen J; Vanneste B; Grabsch HI; Bellezzo M; Paiva Fonseca G; Verhaegen F; Berbee M; Van Limbergen EJ
Radiother Oncol; 2020 Mar; 144():37-45. PubMed ID: 31710942
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
